Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients?
Riggs
B L
BL
D019386:Alendronate / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D015519:Bone Density; D016723:Bone Remodeling; D016903:Drug Monitoring; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D017698:Postmenopause
D015415:Biomarkers; D019386:Alendronate